MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 25.78
-0.16 (-0.62%)
Aug 3, 2026, 2:04 PM CET
MedinCell Ratios and Metrics
Market cap in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 931 | 809 | 476 | 279 | 248 | 187 | |
Market Cap Growth | 61.81% | 69.98% | 70.79% | 12.38% | 32.94% | -35.41% |
Enterprise Value | 901.56 | 781.93 | 463.01 | 318.29 | 296.26 | 206.91 |
Last Close Price | 25.78 | 22.54 | 14.40 | 9.59 | 9.81 | 7.42 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Forward PE | - | 93.68 | 27.96 | 68.00 | 68.00 | 6.91 |
PS Ratio | 38.36 | 41.47 | 18.73 | 30.87 | 25.09 | 22.38 |
PB Ratio | 303.97 | 264.15 | -29.09 | -6.83 | -5.87 | -13.95 |
P/FCF Ratio | - | - | 25.44 | - | - | - |
P/OCF Ratio | - | - | 24.46 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 37.14 | 40.06 | 18.22 | 35.24 | 29.96 | 24.82 |
EV/FCF Ratio | - | - | 24.74 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 17.66 | 17.66 | -3.14 | -1.29 | -0.34 | -1.43 |
Debt / FCF Ratio | - | - | 3.14 | - | - | - |
Net Debt / Equity Ratio | -8.94 | -8.94 | 0.80 | -0.97 | -1.14 | -1.52 |
Net Debt / EBITDA Ratio | 1.16 | 1.16 | 1.18 | -1.78 | -2.15 | -1.12 |
Net Debt / FCF Ratio | 1.08 | 1.08 | -0.70 | -3.23 | -2.23 | -0.88 |
Asset Turnover | 0.18 | 0.20 | 0.40 | 0.27 | 0.27 | 0.15 |
Quick Ratio | 4.31 | 4.31 | 2.51 | 1.32 | 0.15 | 0.73 |
Current Ratio | 4.67 | 4.67 | 2.70 | 1.66 | 0.34 | 0.89 |
Return on Equity (ROE) | -1021.12% | 470.38% | 64.48% | 60.25% | 115.01% | 1168.99% |
Return on Assets (ROA) | -23.58% | -25.68% | -20.82% | -72.33% | -65.31% | -36.27% |
Return on Invested Capital (ROIC) | - | -140.67% | -32.72% | - | - | -493.12% |
Return on Capital Employed (ROCE) | -29.24% | -34.53% | -32.44% | 663.24% | 222.40% | -69.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
FCF Yield | - | - | 3.93% | - | - | - |
Buyback Yield / Dilution | - | -12.60% | -4.28% | -12.83% | -1.30% | -12.80% |
Total Shareholder Return | - | -12.60% | -4.28% | -12.83% | -1.30% | -12.80% |